The secondary packaging market for biologics CDMO is undergoing considerable expansion owing to the rising incidence of chronic illnesses globally. As chronic diseases become more common, the necessity for novel therapies and precision medicine...
Supriya Lifescience's new plant is anticipated to improve production capabilities, aiding its expansion in the competitive pharmaceutical sector. Pharma shares experienced a 6 percent rise after the launch of a modern E-Production Block in...
The PLI scheme will enhance resilience against external shocks, strengthen drug security, and increase the ability to produce critical bulk drugs and higher-value products domestically. The three support schemes revealed by the government will...
Dharampal S Rawat, Senior Director – Cardiovascular, Terumo Aortic and Life Care Solutions in a recent interaction with Industry Outlook magazine shared his views on how advancements in grafts are addressing
The Indian Pharmaceutical Market experienced significant growth, reaching Rs 19,388 crore in November 2024. Strategic pricing played a crucial role in this increase, as several therapies saw price rises. Chronic therapy areas, especially cardiac...
In a workshop hosted by the Central Drugs Standard Control Organization (CDSCO) and FDCA in association with the Indian Drug Manufacturers Association (IDMA), Dr. Naresh Sharma, Deputy Drugs Controller (India), highlights the importance of vendor ...
Sun Pharma maintained its position at the forefront, holding an 8% share in the total pharmaceutical retail market worth Rs 2,28,059 crore. Cipla and Dr Reddy's likewise raised their shares from one month to the next. Throughout the month, both...
The market for pharmaceutical manufacturing equipment is expanding quickly due to the increasing demand for pharmaceuticals, particularly generic medications. Generic medications provide a cost-effective substitute for brand-name drugs and have...
The expansion of Indian CDMOs and CROs will accelerate because of the generally positive environment. As per Mordor Intelligence, the contract manufacturing sector is expected to double within the next five years, reaching $44.63 billion...
The medical devices market ranks as the fourth largest in Asia, following Japan, China, and South Korea, and is among the top twenty medical devices markets globally, expanding at a compound annual growth rate (CAGR) of 15 percent. The production...
, CDSCO.jpg)
